"But the popular idea that this disease only affects immigrants or travelers is dangerously outdated."
www.statnews.com/2025/08/08/c...
@mitchdumais.bsky.social
Infectious Diseases Fellow in Washington, DC by way of @MayoClinic and @UWMedicine. Interests in #Virology, #HIV, #VectorBiology, #Immunology and #Biodefense. Amateur brewer, fisherman, cat dad. ๐ฉบ๐ฆ ๐งฌ๐๐ All views/posts are my own.
"But the popular idea that this disease only affects immigrants or travelers is dangerously outdated."
www.statnews.com/2025/08/08/c...
Measles is horrible. It has already impacted thousands of young kids. This will only grow as vaccines become less accessible.
And when measles is joined by epidemics of rubella, mumps, and polio, we will see children suffer and die at national scale.
www.nbcnews.com/health/healt...
๐จ IDSA has released the first guidelines for the management and treatment of complicated urinary tract infections (cUTIs)!
The new guidelines simplify the prior definitions of uncomplicated UTIs and cUTIs, & address treatment for cUTIs.
View guidelines: bit.ly/4lUjN1a
A very personal decision to donate, but such an amazing gift!
16.07.2025 21:36 โ ๐ 2 ๐ 0 ๐ฌ 0 ๐ 0Text reads 'Over 1.3 million people acquired HIV in 2024. That's 1.3 million more people needing lifelong treatment. A new long-acting prevention option offers hope to tackle this.' Light green background with illustration of a crowd of people and a red ribbon.
Text reads 'Lenacapavir (LEN) is a new drug to protect people at risk of HIV. WHO recommends LEN as an additional PrEP option for HIV prevention.' Light green background with illustration of a medicine bottle and a red ribbon.
Text reads 'Lenacapavir is the first twice-yearly injectable form of PrEP.' Below the text reads - Only 2 doses per year - Highly effective & long-acting - An alternative to daily pills - Designed to be discreet and convenient. Helps fight stigma' Light green background with illustration of a red ribbon.
Text reads 'Diverse HIV prevention options mean more ways for you to take control of your health.' Light green background with illustration of a small group of people smiling and a red ribbon.
โ ๏ธ 1.3 million people acquired HIV in 2024 alone, including thousands of adolescent girls and young women.
Today, in a landmark move towards HIV prevention, WHO recommends twice-yearly injectable lenacapavir as pre-exposure prophylaxis (PrEP) to protect people at risk of HIV.
๐ bit.ly/4lWtzjA
What to do if you are bitten by a Bat?
- copiously wash bite wound with soap and water for at least 15 minutes.
- apply and antiseptic like betadine
- seek medical care urgently- you will like be offered rabies post exposure prophylaxis including vaccination.
bit.ly/3GBBsvy
Peekaboo
10.07.2025 23:34 โ ๐ 4 ๐ 0 ๐ฌ 2 ๐ 0Doxycycline-resistant gonorrhea (tetM) is on the rise:
- Over 14,000 isolates from CDC, 2018 - 2024
- Mean estimated resistance percentage rose from <10% (2020) to >30% (2024)
- Increase in all HHS regions (though largest in Pacific Northwest)
www.nejm.org/doi/full/10....
I will now be solemnly saying "Ah, the Mummy's Curse" for all Aspergillus flavus isolates at Micro Rounds.
29.06.2025 17:25 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0Do you know your HIV status?
Do you know the HIV status of your sexual partner(s)?
Get tested today. All it takes is a few minutes.
If your test is positive, enroll in a Ryan white clinic and get treated - the meds work great.
If your test is negative, consider PrEP to keep it that way.
This is by far the most common vaccine I strongly recommend in ID adult clinical practice. As ID doctors, we see some truly severe cases of zoster, with post-zoster sequelae that may last months or even rarely be permanent. #IDSky doi.org/10.1093/cid/...
26.06.2025 18:53 โ ๐ 64 ๐ 15 ๐ฌ 3 ๐ 1Differentiating inflammation from infection and culturing nontuberculous mycobacteria notoriously difficult
PET tracer 11C-PABA accumulates in live M. abscessus, enabling direct visualization in lung tissue
Data in mouse models and a CF patient show great promise for precision diagnostics
๐ช work
This is what we were waiting for. A direct comparison between apixaban and rivaroxaban for the treatment of acute VTE. Apixaban reduces bleeding risk in the first 3 months by >50%!
Practice changing investigator-initiated RCT.
#ISTH2025
In CID, Xia Wang and colleagues reviewed existing literature to examine the impact of glucocorticoid therapy on vaccination response and safety.
22.06.2025 16:04 โ ๐ 6 ๐ 1 ๐ฌ 0 ๐ 0Cellular and genetic therapies are soon to be in the limelight, with amazing possibilities!
Great opportunities for autoimmune diseases, genetic diseases, and even infectious disease.
โItโs hard to overstate the importance of this for global public health,โ OโDay said, adding that the injection โreally will bend the arc of the epidemic as we roll this out across the globe.โ
But the magnitude of its impact will also depend on how easy it is to get"
ID wishlist:
- *This patient is currently taking prednisone* next to the WBC
- UA/culture results released only after a survey if the patient is experiencing symptoms
- fun GIFs while I review terrifying resistance patterns to boost morale
๐ฌ
03.06.2025 18:54 โ ๐ 0 ๐ 0 ๐ฌ 0 ๐ 0Powerful new tool against Malaria (๐๐ข๐ต๐ถ๐ณ๐ฆ)
Instead of killing mosquitoes, bed nets coated with ELQs (endochin-like quinolones) KILL THE MALARIA PARASITES INSIDE THE INSECTS. Infected mosquitoes land, absorb the drug through their legs, and are rendered parasite-free
www.nature.com/articles/s41...
"...this approach will not only enable scientists to produce gene-editing treatments much more quickly but also far less expensively."
"... it was part of a research project that was supported by the National Institutes of Health."
Investing in Science = Investing in Humanity
#RSV rates in infants are falling. Hospitalizations are down 28 % and 43 % for infants less than 7 months in two different networks, as reported in this week's MMWR.
This is real world evidence that maternal immunization and MAbs are protecting this vulnerable populations - #MedSky.
Bictegravir (BIC)/FTC/TAF makes a first-line appearance in the updated guidelines for PEP!
www.cdc.gov/mmwr/volumes...
Another issue is the AI tool simply copying erroneous notes or errors (which happens enough already). But when it comes from a tool, providers may be less likely to scrutinize and look at the reports themselves.
07.05.2025 14:50 โ ๐ 1 ๐ 0 ๐ฌ 1 ๐ 0105 controlled vaccine trials.
110 yrs. 1.8 M participants.
All in one live, crowd-sourced sheet.
Built by contributors worldwide to counter the myth that vaccines werenโt tested with controls.
Quiet work still breaks through the noise.
www.bradspellberg.com/vaccine-rcts
@bradspellberg.bsky.social
I think the most surprising thing about training in ID is how **broad** the consult requests are.
Fever? Call ID. Elevated WBC? Get ID on board. Recent travel and just don't "seem right?" Touch base with ID.
Even more surprising is how often we find after asking the right questions.
No matter how bad you imagine smallpox was, it was worse than that.
05.05.2025 04:39 โ ๐ 19216 ๐ 3152 ๐ฌ 251 ๐ 54New ๐๐ข๐ต๐ถ๐ณ๐ฆ ๐๐ฆ๐ฅ๐ช๐ค๐ช๐ฏ๐ฆ ๐ฆ
Personalized Nebulized Bacteriophage Therapy for MDR ๐๐ด๐ฆ๐ถ๐ฅ๐ฐ๐ฎ๐ฐ๐ฏ๐ข๐ด Infections in Cystic Fibrosis
In 9 patients, 10ยฒโ10โด CFU/mL drop in sputum bacteria, 6% median gain in FEV1
Post-treatment isolates showed trade-offsโreduced virulence, increased antibiotic susceptibility
The Human Genome Project cost taxpayers $3 Billion.
Two decades on, it has generated a staggering return on investment of $1 Trillion, with benefits in medicine, agriculture, energy, the environment, & more.
If you want to boost the economy, funding science is one of the best things you could do.
I like *one* bunny photo and now every morning I am greeted by bunnies
24.04.2025 11:32 โ ๐ 3 ๐ 1 ๐ฌ 1 ๐ 0*Monet
22.04.2025 01:08 โ ๐ 0 ๐ 0 ๐ฌ 0 ๐ 0